Department of General Surgery, Digestive Surgery Unit, Hospital Universitario y Politecnico La Fe, University of Valencia, Valencia, Spain.
Department of General Surgery, Hospital Universitario de Getafe, Getafe, Madrid, Spain.
Surg Endosc. 2017 Dec;31(12):5032-5042. doi: 10.1007/s00464-017-5548-3. Epub 2017 Apr 28.
Advantages of laparoscopic approach in colon cancer surgery have been previously demonstrated in controlled, randomized trials and in retrospective analysis of large administrative databases. Nevertheless, evidence of these advantages in prospective, observational studies from real-life settings is scarce.
This is a prospective, observational study, including a consecutive series of patients that underwent elective colonic resection for cancer in 52 Spanish hospitals. Pre-/intraoperative data, related to patient, tumor, surgical procedure, and hospital, were recorded as well as 60-day post-operative outcomes, including wound infection, complications, anastomotic leak, length of stay, and mortality. A univariate and multivariate analysis was performed to determine the influence of laparoscopy on short-term post-operative outcome. A sub-analysis of the effect of laparoscopy according to patients' pre-operative risk (ASA Score I-II vs. III-IV) was also performed.
2968 patients were included: 44.2% were initially operated by laparoscopy, with a 13.9% conversion rate to laparotomy. At univariate analysis, laparoscopy was associated with a decreased mortality (p = 0.015), morbidity (p < 0.0001), wound infection (p < 0.0001), and post-operative length of stay (p < 0.0001). At multivariate analysis, laparoscopy resulted as an independent protective factor for morbidity (OR 0.7; p = 0.004), wound infection (OR 0.6; p < 0.0001), and length of post-operative stay (Effect-2 days; p < 0.0001), compared to open approach. These advantages were more relevant in high-risk patients (ASA III-IV), even if the majority of them were operated by open approach (67.1%).
In a real-life setting, laparoscopy decreases wound infection rate, post-operative complications, and length of stay, especially in ASA III-IV patients.
腹腔镜手术在结肠癌手术中的优势已在对照、随机试验和大型行政数据库的回顾性分析中得到证实。然而,在现实环境下的前瞻性、观察性研究中,这些优势的证据很少。
这是一项前瞻性、观察性研究,纳入了 52 家西班牙医院中因癌症接受择期结肠切除术的连续患者系列。记录了术前/术中数据,包括患者、肿瘤、手术过程和医院相关数据,以及术后 60 天的结果,包括伤口感染、并发症、吻合口漏、住院时间和死亡率。进行了单变量和多变量分析,以确定腹腔镜对短期术后结果的影响。还根据患者术前风险(ASA 评分 I-II 与 III-IV)进行了腹腔镜效果的亚分析。
共纳入 2968 例患者:44.2%的患者最初行腹腔镜手术,中转开腹率为 13.9%。单变量分析显示,腹腔镜手术与死亡率降低(p=0.015)、发病率降低(p<0.0001)、伤口感染减少(p<0.0001)和术后住院时间缩短(p<0.0001)相关。多变量分析显示,与开腹手术相比,腹腔镜是发病率(OR 0.7;p=0.004)、伤口感染(OR 0.6;p<0.0001)和术后住院时间(效应-2 天;p<0.0001)的独立保护因素。这些优势在高危患者(ASA III-IV)中更为显著,尽管其中大多数患者行开腹手术(67.1%)。
在真实环境中,腹腔镜手术可降低伤口感染率、术后并发症和住院时间,尤其在 ASA III-IV 患者中。